+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 58 Pages
  • September 2026
  • Region: United States
  • GlobalData
  • ID: 4542842
Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pacific Biosciences of California Inc (Pacific Biosciences) is a life science technology company that designs, develops, and manufactures sequencing solutions. The company's main activities include providing sequencing systems that offer comprehensive views of genomes, transcriptomes, and epigenomes. Its major products include sequencing instruments, Single Molecule, Real-Time (SMRT) Cells, and reagents, which are used in its proprietary SMRT sequencing technology. Pacific Biosciences' products find application in human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It caters to academic and governmental research institutions, genome centers, public health labs, hospitals, commercial testing and service laboratories, clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc Key Recent Developments

  • Aug 05, 2026: PacBio Appoints Mark Van Oene as President and CEO
  • Aug 05, 2026: PacBio Appoints Mark Van Oene as President and Chief Executive Officer
  • Aug 05, 2026: PacBio Announces Second Quarter 2026 Financial Results
  • Aug 05, 2026: PacBio Updates Vega System With Faster Runs, Increased HiFi Output, and Compliance Controls

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Pacific Biosciences of California Inc - Key Facts
  • Pacific Biosciences of California Inc - Key Employees
  • Pacific Biosciences of California Inc - Key Employee Biographies
  • Pacific Biosciences of California Inc - Major Products and Services
  • Pacific Biosciences of California Inc - History
  • Pacific Biosciences of California Inc - Company Statement
  • Pacific Biosciences of California Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Pacific Biosciences of California Inc - Business Description
  • Product Category: Consumable
  • Performance
  • Product Category: Instrument
  • Performance
  • Product Category: Service and Other
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: Europe, Middle East, and Africa
  • Performance
  • R&D Overview
  • Pacific Biosciences of California Inc - Corporate Strategy
  • Pacific Biosciences of California Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Pacific Biosciences of California Inc - Strengths
  • Pacific Biosciences of California Inc - Weaknesses
  • Pacific Biosciences of California Inc - Opportunities
  • Pacific Biosciences of California Inc - Threats
  • Pacific Biosciences of California Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Pacific Biosciences of California Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Pacific Biosciences of California Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 05, 2026: PacBio Appoints Mark Van Oene as President and CEO
  • Aug 05, 2026: PacBio Appoints Mark Van Oene as President and Chief Executive Officer
  • Aug 05, 2026: PacBio Announces Second Quarter 2026 Financial Results
  • Aug 05, 2026: PacBio Updates Vega System With Faster Runs, Increased HiFi Output, and Compliance Controls
  • Jul 31, 2026: GenomOncology to Integrate Pacific Biosciences' HiFi WGS Into Reporting Workflow
  • Jul 08, 2026: Pacific Biosciences of California Announces Board Change
  • Jul 02, 2026: PacBio: Selected Publications April-June 2026
  • Jun 11, 2026: Practical Questions Clinical Research Labs Consider When Adopting HiFi Sequencing
  • May 19, 2026: Blank Bio Announces Seed Financing and Collaboration With PacBio to Advance RNA Foundation Models for Precision Oncology
  • May 11, 2026: HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact Us
  • Disclaimer
List of Tables
  • Pacific Biosciences of California Inc, Key Facts
  • Pacific Biosciences of California Inc, Key Employees
  • Pacific Biosciences of California Inc, Key Employee Biographies
  • Pacific Biosciences of California Inc, Major Products and Services
  • Pacific Biosciences of California Inc, History
  • Pacific Biosciences of California Inc, Other Locations
  • Pacific Biosciences of California Inc, Subsidiaries
  • Pacific Biosciences of California Inc, Key Competitors
  • Pacific Biosciences of California Inc, Ratios based on current share price
  • Pacific Biosciences of California Inc, Annual Ratios
  • Pacific Biosciences of California Inc, Interim Ratios
  • Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Pacific Biosciences of California Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Pacific Biosciences of California Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pacific Biosciences of California Inc, Performance Chart (2021 - 2025)
  • Pacific Biosciences of California Inc, Ratio Charts
  • Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Pacific Biosciences of California Inc, Medical Equipment, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 10X Genomics Inc
  • Qiagen NV
  • Oxford Nanopore Technologies Plc
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc
  • BGI Genomics Co Ltd
  • BioNano Genomics Inc